The Patent Finder

Thrombotech Ltd.

Also on record
Records under this name other than patents Thrombotech Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Thrombotech Ltd.

PatentTitleStatus Expires Confidence
US 8,507,436Peptides derived from plasminogen activator inhibitor-1 and uses thereof
Formerly held
Lapsed on the fee record
Ended Aug 13, 2021 · From the USPTO record
Lapsed on the fee recordEnded Aug 13, 2021From the USPTO record
US 7,271,143Peptides for regulation of urokinase (uPA) and tissue type (tPA) plasminogen activator and method of optimizing therapeutic efficacy
Formerly held
Lapsed on the fee record
Ended Sep 18, 2019 · From the USPTO record
Lapsed on the fee recordEnded Sep 18, 2019From the USPTO record
US 6,759,042Use of cross-linked, covalently bound urokinase plasminogen activator (scuPA)-urokinase plasminogen activator receptor (suPAR) complex as a fibrinolytic agent
Lapsed on the fee record
Ended Jul 6, 2012 · From the USPTO record
Lapsed on the fee recordEnded Jul 6, 2012From the USPTO record
US 6,911,316Medical uses of scuPA/suPAR complex
Lapsed on the fee record
Ended Jun 28, 2009 · From the USPTO record
Lapsed on the fee recordEnded Jun 28, 2009From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited